Tonix Pharmaceuticals Holding Corp. - FORM 10-K - EX-21.01 - SUBSIDIARIES - March 24, 2020

Attached files

file	filename
10-K - ANNUAL REPORT - Tonix Pharmaceuticals Holding Corp.	tnxp-10k_123119.htm
EX-32.01 - CERTIFICATION OF CHIEF EXECUTIVE AND CHIEF FINANCIAL OFFICERS - Tonix Pharmaceuticals Holding Corp.	ex32-01.htm
EX-31.02 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - Tonix Pharmaceuticals Holding Corp.	ex31-02.htm
EX-31.01 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Tonix Pharmaceuticals Holding Corp.	ex31-01.htm
EX-23.01 - CONSENT - Tonix Pharmaceuticals Holding Corp.	ex23-01.htm
EX-10.18 - RESEARCH COLLABORATION AGREEMENT - Tonix Pharmaceuticals Holding Corp.	ex10-18.htm
EX-4.06 - DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED - Tonix Pharmaceuticals Holding Corp.	ex4-06.htm

Tonix Pharmaceuticals Holding Corp. 10-K

Exhibit 21.01

SUBSIDIARIES OF THE COMPANY

Subsidiary Name		State/ Jurisdiction of Incorporation/Formation

Tonix Pharmaceuticals, Inc.		Delaware
Krele, LLC		Delaware
Tonix Pharmaceuticals (Canada), Inc.		New Brunswick, Canada
Tonix Pharma Holdings Limited		Ireland
Tonix Pharma Limited		Ireland
Tonix Medicines, Inc.		Delaware